Basilic vein transposition fistula: a good option for maintaining hemodialysis access site options?

Rao, Rajeev K.; Azin, G.Darius; Hood, Douglas B.; Rowe, Vincent L.; Kohl, Roy D.; Katz, Simon; Weaver, Fred A.

doi:10.1016/j.jvs.2004.01.024

Cited by 86 publications

(75 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…RC AVFs have a reported maturation rate of 25% to 80% [17]. Rao and colleagues reported that failure to mature was as high as 38%, although most other authors have not reported such high rates as this [18]. In our report, maturation rates and times were better than those cited in the literature [11].…”

Section: Discussioncontrasting

confidence: 44%

Secondary Vascular Access Procedures for Hemodialysis After Primary Snuff-Box Arteriovenous Fistula

Kırnap¹

2017

Ann Clin Anal Med

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 44%

Secondary Vascular Access Procedures for Hemodialysis After Primary Snuff-Box Arteriovenous Fistula

Kırnap¹

2017

Ann Clin Anal Med

View full text Add to dashboard Cite

“…The use of ultrasound or other means of preoperative venous mapping is likely to decrease the incidence of primary AVF failures (14 -19). However, the increasing demand to create more fistulas may lead to their creation in borderline vessels, thereby increasing primary failure rates (21)(22)(23). Thus, salvage of these primary failures will be essential for increasing AVF prevalence in the United States.…”

mentioning

confidence: 99%

Endovascular Treatment of the “Failing to Mature” Arteriovenous Fistula

Nassar

Nguyen

Rhee

et al. 2006

Clinical Journal of the American Society of Nephrology

147

100

View full text Add to dashboard Cite

In recent literature, surgically created hemodialysis (HD) arteriovenous fistulas (AVF) have high rates of primary failure. Endovascular treatment holds promise to salvage these fistulae. The outcomes of 119 patients who had a "failing to mature" AVF and presented for endovascular management were evaluated prospectively. All patients underwent a fistulogram. Stenotic lesions underwent balloon angioplasty, and accessory veins underwent obliteration. Technical success was determined immediately after the procedure. AVF salvage was determined by successful use during HD. Patients were followed up for 1 yr, during which primary and secondary AVF patency rates were measured. T he low prevalence of the arteriovenous fistula (AVF) among US hemodialysis (HD) patients (1,2) has initiated nationwide measures to increase AVF creation and prevalence (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). Among these are providing educational programs, setting forth guidelines and goals (3,4), implementing multidisciplinary approaches (4 -9), encouraging preoperative venous mapping (14 -19), and asking surgeons to create AVF instead of arteriovenous grafts (AVG) (10 -21).Overall, an increase in AVF prevalence is occurring in the United States, albeit at a slow rate (14 -20). One impediment has been high primary failure rates, which in recent series ranged between 23 and 46% (9,(12)(13)(14). The use of ultrasound or other means of preoperative venous mapping is likely to decrease the incidence of primary AVF failures (14 -19). However, the increasing demand to create more fistulas may lead to their creation in borderline vessels, thereby increasing primary failure rates (21-23). Thus, salvage of these primary failures will be essential for increasing AVF prevalence in the United States.In our dedicated endovascular suite, we used percutaneous angioplasty and accessory vein obliteration in attempts to salvage fistulas with primary failure. Because most did not present with thrombosis, we elected to refer to their fistulas as "failing to mature." In this article, we report our initial success rates as well as follow-up on a series of 119 consecutive patients who were referred for salvage of their "failing to mature" AVF. Materials and Methods DefinitionsThe "failing to mature" AVF in our series was defined as an AVF that had been created for at least 8 wk but had not matured enough to allow successful cannulation or use during HD. This includes (1) fistulas that were never cannulated for HD be cause of obvious lack of maturity; (2) fistulas that failed first cannulation attempts and were abandoned; (3) fistulas that were cannulated successfully but could not be used because the blood flow was insufficient to sustain HD; this may have been because of high venous pressure or poor arterial inflow; and (4) fistulas that thrombosed before any attempts at HD. Juxta-arterial anastomosis segment refers to the initial 5 cm of the AVF starting at the arterial anastomosis. Peripheral vein refers to the venous outflow tract of t...

show abstract

“…A literature review on the use of systemic intra-operative anticoagulants showed different patterns; while some surgeons use systemic anticoagulants routinely, others preferred heparinized saline for local washing of anastomose site (10)(11)(12)(13)(14)(15)(16)(17).…”

Section: Discussionmentioning

confidence: 99%

Effect of Intra Operative Intravenous Injection of Heparin on Patency Rate of Radio Cephalic Autogenous Arteriovenous-Fistula in Chronic Renal Failure Patients

Ebrahimifard

2015

Arch Crit Care Med

View full text Add to dashboard Cite

Background: Currently, there is no standard for the use of systemic heparin during creation of Arteriovenous (AV) fistula to decrease the incidence of postoperative thrombotic complications. Objectives: The goal of this study was to evaluate the effects of intra-operative IV heparin on patency rate and postoperative bleeding complications in patients undergoing surgery for AV fistula. Patients and Methods: A prospective, randomized controlled study was performed on 50 patients undergoing AV fistula creation, who were randomly divided in two groups. The control group received no systemic heparin and the heparin group received 5,000 units of intravenous heparin before clamping of theartery. Results: There was a significant difference in patency rate between the heparin and control groups (96% vs. 72%, P = 0.021), and there were no significant differences in operative time (P = 0.55). Perioperative bleeding was not significantly different between the two groups. Conclusions:The results suggest that intra operative administration of heparin has statistically significant effects on patency rates yet not on postoperative bleeding complications. Larger trials with longer follow-up durations and assessment of maturation rates are needed to determine this effect on fistula outcome.

show abstract

Basilic vein transposition fistula: a good option for maintaining hemodialysis access site options?

Cited by 86 publications

References 10 publications

Secondary Vascular Access Procedures for Hemodialysis After Primary Snuff-Box Arteriovenous Fistula

Secondary Vascular Access Procedures for Hemodialysis After Primary Snuff-Box Arteriovenous Fistula

Endovascular Treatment of the “Failing to Mature” Arteriovenous Fistula

Effect of Intra Operative Intravenous Injection of Heparin on Patency Rate of Radio Cephalic Autogenous Arteriovenous-Fistula in Chronic Renal Failure Patients

Contact Info

Product

Resources

About